Comparative study of the efficacy and tolerability of dihydroartemisinin - Piperaquine - trimethoprim versus artemether - Lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Menan, Hervé ^a   Faye, Oumar ^b   Same Ekobo, Albert ^c   Oga, Agbaya Serge S ^a   Faye, Babacar ^b   Kiki Barro, Christiane P ^a   Kuete, Thomas ^d   N'Diaye, Jean Louis ^b   Vicky, Ama Moor ^e   Tine, Rogert ^b   Yavo, William ^a   Kane, Dieynaba ^b   Kassi, Kondo F ^a   Kone, Moussa ^a  

^a UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c University Hospital Center of Yaounde   (Cameroon)

^d UNIVERSITY OF DOUALA   (Cameroon)

^e UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ARTECOM; ARTEMETHER; BENFLUMETOL; DIHYDROARTEMISININ; PIPERAQUINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; QUINOLINE DERIVATIVE;

ABDOMINAL PAIN; ADOLESCENT; APHTHOUS ULCER; ARTICLE; ASTHENIA; CAMEROON; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COTE D'IVOIRE; COUGHING; DIARRHEA; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; EPIGASTRIC PAIN; FACE EDEMA; FEMALE; FEVER; FOLLOW UP; HUMAN; HYPOGLYCEMIA; INSOMNIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NAUSEA; PARASITE CLEARANCE; POLYMERASE CHAIN REACTION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SENEGAL; SKIN DEFECT; VOMITING; WORLD HEALTH ORGANIZATION; ADULT; ANIMAL; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG COMBINATION; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; CAMEROON; CHILD; CHILD, PRESCHOOL; COTE D'IVOIRE; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; QUINOLINES; SENEGAL; TREATMENT OUTCOME; TRIMETHOPRIM; YOUNG ADULT;

EID: 79959993114     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-185     Document Type: Article

References (17)

1. Artemisinin resistance in Plasmodium falciparum malaria. AM Dondorp F Nosten P Yi D Das AP Phyo J Tarning KM Lwin F Ariey W Hanpithakpong SJ Lee P Ringwald K Silamut M Imwong K Chotivanich P Lim T Herdman SS An S Yeung P Singhasivanon NP Day N Lindegardh D Socheat NJ White, N Engl J Med 2009 361 455 67 10.1056/NEJMoa0808859 19641202
2. Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine- pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies. M Bonnet I Broek M van Herp PP Urrutia C van Overmeir J Kyomuhendo CN Ndosimao E Ashley JP Guthmann, Malar J 2009 8 192 10.1186/1475-2875-8-192 19664280
3. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine- pyrimethamine with mefloquine. V Briand J Bottero H Nol V Masse H Cordel J Guerra H Kossou B Fayomi P Ayemonna N Fievet A Massougbodji M Cot, J Infect Dis 2009 200 991 1001 10.1086/605474 19656069
4. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009. NV Thanh TQ Toan AF Cowman GJ Casey BQ Phuc NT Tien NM Hung BA Biggs, Malar J 2010 9 181 10.1186/1475-2875-9-181 20573274
5. Malaria treatment by using artemisinin in Indonesia. PN Harijanto, Acta Med Indones 2010 42 51 6 20305333
6. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007. P Lim C Wongsrichanalai P Chim N Khim S Kim S Chy R Sem S Nhem P Yi S Duong DM Bouth B Genton HP Beck JG Gobert WO Rogers JY Coppee T Fandeur O Mercereau-Puijalon P Ringwald J Le Bras F Ariey, Antimicrob Agents Chemother 2010 54 2135 42 10.1128/AAC.01304-09 20194689
7. Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria. K Congpuong P Bualombai V Banmairuroi K Na-Bangchang, Malar J 2010 9 43 10.1186/1475-2875-9-43 20132537
8. Seasonal distribution of anti-malarial drug resistance alleles on the island of Sumba, Indonesia. PB Asih WO Rogers AI Susanti A Rahmat IE Rozi MA Kusumaningtyas RM Dewi FN Coutrier A Sutamihardja AJ van der Ven RW Sauerwein D Syafruddin, Malar J 2009 8 222 10.1186/1475-2875-8-222 19788738
9. Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali. AA Djimdé B Fofana I Sagara B Sidibe S Toure D Dembele S Dama D Ouologuem A Dicko OK Doumbo, Am J Trop Med Hyg 2008 78 455 61 18337343 (Pubitemid 351845197)
10. World Health Organisaton (WHO), Assessment and monitoring of antimalarial drug efficacy for treatment of uncomplicated falciparum malaria Document no. WHO/HTM/RBM/2003.50. Geneva, Switzerland 2003
11. Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children. S Katrak A Gasasira E Arinaitwe A Kakuru H Wanzira V Bigira TG Sandison J Homsy JW Tappero MR Kamya G Dorsey, Malar J 2009 8 272 10.1186/1475-2875-8-272 19948038
12. Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. Q Bassat M Mulenga H Tinto P Piola S Borrmann C Menéndez M Nambozi I Valéa C Nabasumba P Sasi A Bacchieri M Corsi D Ubben A Talisuna U D'Alessandro, PLoS One 2009 4 7871 10.1371/journal.pone.0007871 19936217
13. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. E Arinaitwe TG Sandison H Wanzira A Kakuru J Homsy J Kalamya MR Kamya N Vora B Greenhouse PJ Rosenthal J Tappero G Dorsey, Clin Infect Dis 2009 49 1629 37 10.1086/647946 19877969
14. Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China. SQ Wang E Christophel SG Lin F Meng XM Hu GZ Wang J Liu LH Zeng, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2008 26 50 2 18637586
15. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. A Yeka G Dorsey MR Kamya A Talisuna M Lugemwa JB Rwakimari SG Staedke PJ Rosenthal F Wabwire-Mangen H Bukirwa, PLoS One 2008 3 2390 10.1371/journal.pone.0002390 18545692
16. Dihydroartemisinin-piperaquine versus artemether-lumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central Sudan. I Adam MT Salah HG Eltahir AH Elhassan KA Elmardi EM Malik, Ann Trop Med Parasitol 2010 104 319 26 10.1179/136485910X12743554760144 20659392
17. CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam. PT Giao PJ de Vries Q Hung le TQ Binh NV Nam PA Kager, Trop Med Int Health 2004 9 209 16 10.1046/j.1365-3156.2003.01180.x 15040557 (Pubitemid 38250807)